The Effects of a Novel Curcumin Derivative Loaded Long-Circulating Solid Lipid Nanoparticle on the MHCC-97H Liver Cancer Cells and Pharmacokinetic Behavior

References

• Cortes J, Perez-García JM, Llombart-Cussac A, et al. Enhancing Global Access to Cancer Medicines. CA Cancer J Clin. 2020;70:105–124.
   PubMed Web of Science ®Google Scholar
• Chen WT, Hsu FT, Liu YC, et al. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro. Int J Mol Sci. 2019;20:757–772.
   PubMed Web of Science ®Google Scholar
• Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol. 2009;15:513–520.
   PubMed Web of Science ®Google Scholar
• Guo P, Pi C, Zhao S, et al. Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer. Expert Opin Drug Deliv. 2020;17:1473–1484.
   PubMed Web of Science ®Google Scholar
• Chen TW, Yin FF, Yuan YM, et al. Promotes Liver Cancer Metastasis by Facilitating Rab14 Recycle. Nat Commun. 2019;10(1):10–25.
   PubMedGoogle Scholar
• Vecchione R, Quagliariello V, Calabria D, et al. Curcumin bioavailability from oil in water nano-emulsions: in vitro and in vivo study on the dimensional, compositional and interactional dependence. J Control Release. 2016;233:88–100.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Harsha C, Banik K, et al. Is Curcumin Bioavailability a Problem in Humans: lessons From Clinical Trials. Expert Opin Drug Metab Toxicol. 2019;15(9):705–733.
   PubMed Web of Science ®Google Scholar
• Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, et al. Substantiation for the Use of Curcumin During the Development of Neurodegeneration After Brain Ischemia. Int J Mol Sci. 2020;21(2):517.
   PubMed Web of Science ®Google Scholar
• Sadeghianmaryan A, Yazdanpanah Z, Soltani YA, et al. Curcumin-loaded Electrospun Polycaprolactone/Montmorillonite Nanocomposite: wound Dressing Application With Anti-Bacterial and Low Cell Toxicity Properties. J Biomater Sci Polym Ed. 2020;31(2):169–187.
   PubMed Web of Science ®Google Scholar
• Rodrigues FC, Anil Kumar NV, Thakur G. Developments in the anticancer activity of structurally modified curcumin: an up-to-date review. Eur J Med Chem. 2019;177:76–104.
   PubMed Web of Science ®Google Scholar
• Santezi C, Reina BD, Dovigo LN. Curcumin-mediated Photodynamic Therapy for the Treatment of Oral infections-A Review. Photodiagnosis Photodyn Ther. 2018;21:409–415.
   PubMed Web of Science ®Google Scholar
• Mhd AT, Roja H, Zhao X. A Review of Curcumin and Its Derivatives as Anticancer Agents. Int J Mol Sci. 2019;20(5):1–26.
   Web of Science ®Google Scholar
• Mu J, Wang X, Dong L, et al. Curcumin Derivative L6H4 Inhibits Proliferation and Invasion of Gastric Cancer Cell Line BGC-823. J Cell Biochem. 2019;120(1):11–17.
   Web of Science ®Google Scholar
• Feng T. Preparation of naturally effective monomer CU derivative (CU1), construction and evaluation of its nanoparticle delivery system (CU1-SLN). Southwest Medical University. 2018;3:42.
   Google Scholar
• Sean D. Caplacizumab: first Global Approval. Drugs. 2018;78(15):39–42.
   PubMed Web of Science ®Google Scholar
• Gianni L, Mansutti M, Anton A, et al. Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: a Randomized Phase 3 Clinical Trial. JAMA Oncol. 2018;4(3):302–308.
   PubMed Web of Science ®Google Scholar
• Westhauser F, Essers C, Karadjian M, et al. Supplementation With 45S5 Bioactive Glass Reduces In Vivo Resorption of the β-Tricalcium-Phosphate-Based Bone Substitute Material Vitoss. Int J Mol Sci. 2019;20(17):1–10.
   Web of Science ®Google Scholar
• Pathade AD, Kommineni N, Bulbake U, et al. Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib. AAPS PharmSciTech. 2019;20(7):276–289.
   PubMed Web of Science ®Google Scholar
• Truffi M, Mazzucchelli S, Bonizzi A, et al. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy. Int J Mol Sci. 2019;20(6):1–18.
   Web of Science ®Google Scholar
• Liu X, Jiang J, Meng H. Transcytosis - An Effective Targeting Strategy That Is Complementary to “EPR Effect” for Pancreatic Cancer Nano Drug Delivery. Theranostics. 2019;9(26):18–25.
   Web of Science ®Google Scholar
• Lim C, Moon J, Sim T, et al. A Nano-Complex System to Overcome Antagonistic Photo-Chemo Combination Cancer Therapy. J Control Release. 2019;295:164–173.
   PubMed Web of Science ®Google Scholar
• Chugh H, Sood D, Chandra I, et al. Role of Gold and Silver Nanoparticles in Cancer Nano-Medicine. Artif Cells Nanomed Biotechnol. 2018;46:10–20.
   Web of Science ®Google Scholar
• Chetoni P, Burgalassi S, Monti D, et al. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits. Eur J Pharm Biopharm. 2016;109:214–223.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Shegokar R, Souto EB. Role of excipients in formulation development and biocompatibility of lipid nanoparticles (SLN/NLCs). Nanostructures for Novel Therapy. 2017;1:811–843.
   Google Scholar
• Parhi P, Suklabaidya S, Kumar Sahoo S. Enhanced Anti-Metastatic and Anti-Tumorigenic Efficacy of Berbamine Loaded Lipid Nanoparticles in Vivo. Sci Rep. 2017;7(1):5806–5819.
   PubMed Web of Science ®Google Scholar
• Umang S, Garima J, Krutika S. Improvement in Antihypertensive and Antianginal Effects of Felodipine by Enhanced Absorption From PLGA Nanoparticles Optimized by Factorial Design. Mater Sci Eng C Mater Biol Appl. 2014;35:153–163.
   PubMed Web of Science ®Google Scholar
• Wei YM, Xue ZK, Wang P, et al. Formulation and pharmacokinetic evaluation of once-daily sustained-released system of nifedipine with solid dispersion and coating techniques. Arch Pharm Res. 2013;36(7):864–873.
   PubMed Web of Science ®Google Scholar
• Thiramanas R, Jiang S, Simon J, et al. Silica Nanocapsules with Different Sizes and Physicochemical Properties as Suitable Nanocarriers for Uptake in T-Cells. Int J Nanomedicine. 2020;15:6069–6084.
   PubMed Web of Science ®Google Scholar
• Pindiprolu SKSS, Chintamaneni PK, Krishnamurthy PT, et al. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. Drug Dev Ind Pharm. 2019;45(2):304–313.
   PubMed Web of Science ®Google Scholar
• Luo H, Lu L, Liu N, et al. Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis. J Nanobiotechnology. 2021;19:224.
   PubMed Web of Science ®Google Scholar
• Tan L, Peng J, Zhao Q, et al. A Novel MPEG-PDLLA-PLL Copolymer for Docetaxel Delivery in Breast Cancer Therapy. Theranostics. 2017;7:2652–2672.
   PubMed Web of Science ®Google Scholar
• Deng C, Zhang Q, He P, et al. Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nat Commun. 2021;12:2174.
   PubMed Web of Science ®Google Scholar
• Xiao L, Bei Y, Li J, et al. Preclinical Pharmacokinetics, Tissue Distribution and Primary Safety Evaluation of a Novel Curcumin Analogue H10 Suspension, a Potential 17β Hydroxysteroid Dehydrogenase Type 3 Inhibitor. Chem Pharm Bull (Tokyo). 2021;69(1):52–58.
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol. 2011;670:372–383.
   PubMed Web of Science ®Google Scholar
• Wei Q, Yang Q, Wang Q, et al. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. AAPS PharmSciTech. 2018;19(8):3661–3669.
   PubMed Web of Science ®Google Scholar
• Jia L, Shen J, Zhang D, et al. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol. 2012;50:523–529.
   PubMed Web of Science ®Google Scholar
• Feng X, Pi C, Fu S, et al. Combination of curcumin and paclitaxel liposomes exhibits enhanced cytotoxicity towards A549/A549-T cells and unaltered pharmacokinetics. J Biomed Nanotechnol. 2020;16:1304–1313.
   PubMedGoogle Scholar
• Chen J, Cheng D, Li J, et al. Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC. Drug Dev Ind Pharm. 2013;39(2):197–204.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liang H, Yao H, et al. The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation in vitro as well as pharmacokinetics in rats. Drug Dev Ind Pharm. 2019;45(7):1052–1060.
   PubMed Web of Science ®Google Scholar
• Omwoyo WN, Melariri P, Gathirwa JW, et al. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles. Nanomedicine. 2016;12(3):801–809.
   PubMed Web of Science ®Google Scholar
• Tian L, Gao J, Yang Z, et al. Tamibarotene-Loaded PLGA Microspheres for Intratumoral Injection Administration: preparation and Evaluation. AAPS PharmSciTech. 2018;19(1):275–283.
   PubMed Web of Science ®Google Scholar
• Yeh CB, Hsieh MJ, Hsieh YH, et al. Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity. PLoS One. 2012;7(2):e31055.
   PubMed Web of Science ®Google Scholar
• Ardito F, Perrone D, Giuliani M, et al. Ardito, Effects of curcumin on squamous cell carcinoma of tongue: an in vitro study. Curr Top Med Chem. 2018;18(3):233–243.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun W, Han N, et al. Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK/STAT pathway. BMC Cancer. 2018;18:1230–1239.
   PubMed Web of Science ®Google Scholar
• Alakhova DY, Kabanov AV. Pluronics and MDR reversal: an update. Mol Pharm. 2014;11(8):2566–2578.
   PubMed Web of Science ®Google Scholar
• Weng CJ, Chau CF, Hsieh YS, et al. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis. 2008;29:147–156.
   PubMed Web of Science ®Google Scholar
• Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278:16–27.
   PubMed Web of Science ®Google Scholar
• Liu JF, Zhang SW, Jamieson GG, et al. The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo. Int J Cancer. 2008;122(7):1639–1644.
   PubMed Web of Science ®Google Scholar
• Mingao Z, Lei C. Inhibition of curcumin on human lung adenocarcinoma LTEP-A2 cells and its mechanism. Pak J Pharm Sci. 2019;32:1307–1311.
   PubMed Web of Science ®Google Scholar
• Wang N, Feng T, Liu X, et al. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway. Acta Pharm. 2020;70(3):399–409.
   PubMed Web of Science ®Google Scholar
• Erel-Akbaba G, Carvalho LA, Tian T, et al. Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy. ACS Nano. 2019;13(4):4028–4040.
   PubMed Web of Science ®Google Scholar
• Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Drug Delivery Rev. 2003;55:403–419.
   PubMed Web of Science ®Google Scholar
• Vonarbourg A, Passirani C, Saulnier P, et al. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials. 2006;27:4356–4373.
   PubMed Web of Science ®Google Scholar